Risk factors for non-cancer death after surgery in patients with stage I non-small-cell lung cancer.


Journal

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
ISSN: 1873-734X
Titre abrégé: Eur J Cardiothorac Surg
Pays: Germany
ID NLM: 8804069

Informations de publication

Date de publication:
13 04 2021
Historique:
received: 06 04 2020
revised: 31 07 2020
accepted: 11 08 2020
entrez: 13 4 2021
pubmed: 14 4 2021
medline: 2 7 2021
Statut: ppublish

Résumé

With improvements in the outcome of treatment for non-small-cell lung cancer (NSCLC), other diseases may account for a high death rate after surgery in patients with stage I NSCLC. In the present study, we analysed the associations between the clinical factors and non-cancer death after surgery in these patients. The records of 514 patients with stage I NSCLC who underwent surgery were retrospectively reviewed; a proportional hazards model for the subdistribution of a competing risk was conducted to define the risk factors for non-cancer death. The mean patient age was 67 years. A total of 367 patients (71%) underwent bilobectomy or lobectomy while 147 (29%) underwent sublobar resection. The pathological stage was IA in 386 (75%) and IB in 128 (25%) patients. Three patients (0.6%) died within 90 days after surgery, and 108 (21%) experienced postoperative complications. Until the time of writing this report, 83 patients had died during the follow-up. The cause of death was primary lung cancer in 38 (46%) patients and other diseases in 45 (54%) patients, including non-cancer causes in 29 patients, such as pneumonia, cardiac death and cerebral stroke. According to a multivariable competing risk analysis for non-cancer death age (≥70 years), sex (male), body mass index (BMI <18.5), postoperative complications and % forced expiratory volume in 1 s (<80) were identified as risk factors for postoperative non-cancer death. Advanced age (≥70 years), male sex, low BMI (<18.5), postoperative complications and low preoperative % forced expiratory volume in 1 s (<80) were found to be the risk factors for postoperative non-cancer death after surgery in patients with stage I NSCLC.

Identifiants

pubmed: 33849065
pii: 6012804
doi: 10.1093/ejcts/ezaa333
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

633-640

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Auteurs

Ryu Kanzaki (R)

Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, Suita, Japan.

Akihiro Nagoya (A)

Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, Suita, Japan.

Takashi Kanou (T)

Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, Suita, Japan.

Naoko Ose (N)

Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, Suita, Japan.

Soichiro Funaki (S)

Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, Suita, Japan.

Masato Minami (M)

Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, Suita, Japan.

Yuna Okamoto (Y)

Laboratory for Clinical Investigation, Osaka University Hospital, Suita, Japan.

Hiroto Tabuchi (H)

Laboratory for Clinical Investigation, Osaka University Hospital, Suita, Japan.

Tomoko Hoshino (T)

Laboratory for Clinical Investigation, Osaka University Hospital, Suita, Japan.

Tetsuya Tajima (T)

Department of Mathematical Health Science, Osaka University Graduate School of Medicine, Suita, Japan.

Makoto Fujii (M)

Department of Mathematical Health Science, Osaka University Graduate School of Medicine, Suita, Japan.

Yuko Ohno (Y)

Department of Mathematical Health Science, Osaka University Graduate School of Medicine, Suita, Japan.

Yasushi Shintani (Y)

Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, Suita, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH